Active autophagy in the tumor microenvironment: A novel mechanism for cancer metastasis

Yinghua Xu1, Xiaoping Xia, Hongming Pan

  • 1Departments of Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.

Oncology Letters
|February 20, 2013
PubMed

Insights

Autophagy, a cellular recycling process, initially prevents tumors but aids established cancers. Understanding its role in metastasis could lead to new cancer treatments.

Area of Science:

  • Cellular Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Autophagy is a fundamental lysosomal degradation pathway essential for cellular homeostasis and survival under stress.
  • Evidence suggests autophagy acts as a tumor suppressor in early tumorigenesis.
  • Its role in established tumors, particularly in cancer metastasis, remains largely unknown.

Purpose of the Study:

  • To review the role of autophagy in the context of the tumor microenvironment.
  • To explore the mechanisms by which autophagy influences cancer metastasis.
  • To discuss the potential of targeting autophagy for anti-metastasis cancer therapies.

Main Methods:

  • Literature review of current research on autophagy and cancer metastasis.
  • Analysis of the tumor microenvironment's influence on autophagic activity.
  • Discussion of potential therapeutic strategies targeting autophagic pathways.

Main Results:

  • Autophagy promotes cancer cell survival in established tumors and under stress conditions like chemotherapy.
  • The abnormal tumor environment can induce autophagy, potentially promoting metastasis.
  • The precise mechanisms linking autophagy to cancer metastasis require further elucidation.

Conclusions:

  • Autophagy plays a dual role in cancer, suppressing early tumorigenesis but promoting progression and survival in established tumors.
  • Manipulating autophagy presents a promising therapeutic avenue for combating cancer metastasis.
  • Further research is needed to fully understand and exploit autophagy's role in metastasis for clinical benefit.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...